- Home
- AMC vs BBNX Comparison
AMC vs BBNX Comparison
Compare AMC & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMC | BBNX |
|---|---|---|
| Founded | 1920 | 2015 |
| Country | United States | United States |
| Employees | N/A | 423 |
| Industry | Movies/Entertainment | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 577.2M | 493.1M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMC | BBNX |
|---|---|---|
| Price | $0.95 | $10.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $2.03 | ★ $26.22 |
| AVG Volume (30 Days) | ★ 23.3M | 973.9K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,848,900,000.00 | N/A |
| Revenue This Year | $10.60 | $34.99 |
| Revenue Next Year | $4.72 | $34.47 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.57 | N/A |
| 52 Week Low | $0.93 | $8.89 |
| 52 Week High | $4.08 | $32.71 |
Technical Indicators
Market Signals| Indicator | AMC | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 26.81 | 37.23 |
| Support Level | N/A | $9.91 |
| Resistance Level | $1.25 | $15.53 |
| Average True Range (ATR) | 0.05 | 0.59 |
| MACD | 0.00 | 0.29 |
| Stochastic Oscillator | 12.85 | 46.02 |
Price Performance
Historical ComparisonAbout AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.